Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized trial of add‐on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy
Karin Borges, Neha Kaul, Jack Germaine, et al.
Epilepsia Open (2019) Vol. 4, Iss. 1, pp. 153-163
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle
Jens V. Andersen, Arne Schousboe, Alexei Verkhratsky
Progress in Neurobiology (2022) Vol. 217, pp. 102331-102331
Closed Access | Times Cited: 159
Role of Medium-Chain Fatty Acids in Healthy Metabolism: A Clinical Perspective
Lili Huang, Lin Gao, Chen Chen
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 6, pp. 351-366
Closed Access | Times Cited: 70
Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply
Jens V. Andersen, Emil W. Westi, Emil Jakobsen, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Glial Glutamine Homeostasis in Health and Disease
Jens V. Andersen, Arne Schousboe
Neurochemical Research (2022) Vol. 48, Iss. 4, pp. 1100-1128
Closed Access | Times Cited: 47
Anaplerosis by medium-chain fatty acids through complex interplay with glucose and glutamine metabolism
Hannah M. German, Jolita Čiapaitė, Nanda M. Verhoeven‐Duif, et al.
Journal of Biological Chemistry (2025), pp. 108307-108307
Open Access | Times Cited: 1
Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies
Felicity Y. Han, Lisa Conboy‐Schmidt, Galena Rybachuk, et al.
Epilepsia (2021) Vol. 62, Iss. 8, pp. 1790-1806
Open Access | Times Cited: 56
A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice
Stéphanie Mourad, Abdualrahman Mohammed Abdualkader, Xiaobei Li, et al.
Experimental Physiology (2024) Vol. 109, Iss. 3, pp. 350-364
Open Access | Times Cited: 5
Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice
Eric S. Goetzman, Sivakama S. Bharathi, Yuxun Zhang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Updates on the ketogenic diet therapy for pediatric epilepsy
Ara Ko, Hye Eun Kwon, Heung Dong Kim
Biomedical Journal (2021) Vol. 45, Iss. 1, pp. 19-26
Open Access | Times Cited: 32
Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
Evgenia Sklirou, Ahmad Alodaib, Steven F. Dobrowolski, et al.
Frontiers in Genetics (2021) Vol. 11
Open Access | Times Cited: 30
Triheptanoin: First Approval
Matt Shirley
Drugs (2020) Vol. 80, Iss. 15, pp. 1595-1600
Open Access | Times Cited: 31
Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease
Aishat O. Ameen, Kristine Freude, Blanca I. Aldana
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2778-2778
Open Access | Times Cited: 18
Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases
Zeinab Wehbe, Sara Tucci
Journal of Inherited Metabolic Disease (2019) Vol. 43, Iss. 3, pp. 385-391
Open Access | Times Cited: 18
Metabolic aspects of genetic ion channel epilepsies
Elliott S. Neal, Weizhi Xu, Karin Borges
Journal of Neurochemistry (2023)
Open Access | Times Cited: 5
Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β‐oxidation deficient cells: A comparative study
Anuradha Karunanidhi, Clinton Van’t Land, Dhivyaa Rajasundaram, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 45, Iss. 3, pp. 541-556
Open Access | Times Cited: 9
Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model
Tanya S. McDonald, Elliott S. Neal, Karin Borges
Epilepsy & Behavior (2021) Vol. 122, pp. 108223-108223
Closed Access | Times Cited: 10
Transient anticonvulsant effects of time-restricted feeding in the 6-Hz mouse model
Oliver J. Armstrong, Elliott S. Neal, Diana Vidovic, et al.
Epilepsy & Behavior (2024) Vol. 151, pp. 109618-109618
Open Access | Times Cited: 1
Case for supporting astrocyte energetics in glucose transporter 1 deficiency syndrome
Weizhi Xu, Karin Borges
Epilepsia (2024) Vol. 65, Iss. 8, pp. 2213-2226
Open Access | Times Cited: 1
Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
Karin Borges, Neha Kaul, Jack Germaine, et al.
Epilepsia Open (2020) Vol. 5, Iss. 2, pp. 230-239
Open Access | Times Cited: 10
Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer’s Disease
Xiaodong Yuan, Lu Wang, Neha Tandon, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 1, pp. 425-437
Open Access | Times Cited: 9
Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency
Anuradha Karunanidhi, Shakuntala Basu, Xuejun Zhao, et al.
Molecular Genetics and Metabolism (2023) Vol. 140, Iss. 3, pp. 107689-107689
Open Access | Times Cited: 3
Alterations in mitochondrial glucose carbon metabolism in epilepsy and targeted metabolic treatments
Felicity Y. Han, Tanya S. McDonald, Weizhi Xu, et al.
Clinical bioenergetics (2020), pp. 653-677
Closed Access | Times Cited: 3
Triheptanoin as a nutraceutical and its potential use in epilepsy
Giovanna Testa, Mario Costa, Marco Mainardi
Elsevier eBooks (2023), pp. 361-377
Closed Access | Times Cited: 1
Advances in Ketogenic Diet Therapies in Pediatric Epilepsy
Battamir Enkhtuy, Hye Eun Kwon, Heung Dong Kim
Annals of Child Neurology (2019) Vol. 27, Iss. 4, pp. 105-112
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top